HDL, often called “good cholesterol,” is considered protective when it falls at or above 40 mg/dL for men and 50 mg/dL for women, with levels of 60 mg/dL and above traditionally viewed as heart-healthy. But the story is more layered than a single number on a lab printout. Recent research has shifted attention from how much HDL you have to how well it works, and even shown that very high levels can carry their own risks.
What HDL Actually Does in Your Body
HDL stands for high-density lipoprotein, and its main job is hauling excess cholesterol out of your arteries and back to the liver, where it gets broken down and removed. This process is called reverse cholesterol transport. HDL particles pick up cholesterol from cells lining blood vessel walls and ferry it away before it can build up into the fatty plaques that narrow arteries and set the stage for heart attacks and strokes.1PubMed Central. Lipoproteins and Their Effects on the Cardiovascular System The process involves specific protein-receptor interactions on cell surfaces, not just passive contact between particles.2PubMed. High-density lipoproteins and endothelial function
That cleanup role is important, but HDL does more than just shuttle cholesterol. It has anti-inflammatory, antioxidant, and anti-clotting properties. One of the more interesting effects is that HDL stimulates the production of nitric oxide in blood vessel walls, a molecule that keeps arteries relaxed and dilated.3PubMed Central. HDL and endothelial protection HDL also protects the endothelial progenitor cells that help repair damaged artery linings.4PubMed. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis So the particle is not just a garbage truck for cholesterol; it actively defends the cardiovascular system in several ways simultaneously.
Standard Ranges and What They Mean
Most doctors use these cutoffs when reading your lipid panel:
- Below 40 mg/dL (men) or below 50 mg/dL (women): considered low and a risk factor for heart disease.
- 40–59 mg/dL: acceptable, though higher is generally better within this range.
- 60 mg/dL and above: traditionally regarded as protective.
Large epidemiological data consistently show that HDL levels are inversely associated with cardiovascular events, meaning the higher your HDL, the lower your risk tends to be.5PubMed. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events In one multi-ethnic study that followed participants for about a decade, people with isolated low HDL (below those sex-specific thresholds, with otherwise favorable lipid numbers) had roughly double the risk of coronary heart disease compared to people with optimal lipid profiles.6American Journal of Epidemiology. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death
These ranges are useful starting points, but they are not the whole picture. Two people with identical HDL numbers can have very different cardiovascular risk, which is why researchers have moved beyond simply measuring the amount of HDL cholesterol in your blood.
Why the Number on Your Lab Report Is Not the Full Story
The biggest shift in HDL research over the past decade has been the realization that HDL quality matters at least as much as HDL quantity. The key measure researchers now focus on is called cholesterol efflux capacity, which is essentially a lab test of how effectively your HDL particles pull cholesterol out of cells. Think of it as a performance rating for your HDL rather than a headcount.
A landmark study published in the New England Journal of Medicine found that after adjusting for traditional risk factors, people in the top quarter of cholesterol efflux capacity had about a 67% lower cardiovascular risk compared to people in the bottom quarter. The striking part: the actual HDL cholesterol number on a standard lab panel was not independently associated with cardiovascular events once efflux capacity was accounted for.7PubMed Central. HDL cholesterol efflux capacity and incident cardiovascular events A separate prospective study found the same pattern: after adjusting for efflux capacity, the protective association that HDL cholesterol and its main protein had with heart disease weakened and became statistically insignificant.8PubMed Central. Association of HDL cholesterol efflux capacity with incident coronary heart disease events A systematic review and meta-analysis confirmed the broader trend: HDL’s ability to remove cholesterol from cells is inversely associated with cardiovascular risk, and this relationship holds independent of how much HDL cholesterol is circulating.9PubMed Central. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk
Efflux capacity testing is not yet standard on a routine lab panel. Some advanced lipid testing options measure HDL particle number and size using nuclear magnetic resonance spectroscopy, and there is evidence that a higher total HDL particle count and larger average particle size are associated with lower coronary risk.10PubMed. High-density lipoprotein particle size and concentration and coronary risk These tests are available at some labs and are occasionally ordered by cardiologists or lipid specialists, but they remain far from routine.
The U-Shaped Curve and Very High HDL
For years, the assumption was straightforward: higher HDL equals lower risk, no upper limit. That assumption has been challenged. A study drawing on UK Biobank data and a separate high-risk cohort found a U-shaped relationship between HDL cholesterol and adverse cardiovascular outcomes. Both very low and very high HDL levels were associated with increased risk compared to levels in the middle range.11JAMA Cardiology. Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations
Why would extremely high HDL be harmful? One leading explanation involves dysfunctional HDL. Chronic or acute inflammation can alter the structure and protein cargo of HDL particles, effectively converting them from protective to pro-inflammatory.12PubMed Central. Dysfunctional high-density lipoprotein: an updated review Enzymes associated with inflammation can chemically modify the main protein on HDL (apolipoprotein A-I), impairing its ability to pull cholesterol out of cells and instead activating inflammatory pathways that promote artery disease.13PubMed Central. Dysfunctional HDL and atherosclerotic cardiovascular disease So a person with very high HDL cholesterol might have a large number of particles that are essentially broken, present in abundance but not doing their job.
The practical upshot: an HDL level of 90 or 100 mg/dL is not automatically better than one of 65. If your HDL is unusually high and your doctor has no clear explanation (such as regular intense exercise or a known genetic trait), it may be worth discussing further evaluation rather than celebrating the number.
HDL Subfractions and Whether They Matter Clinically
HDL is not a single uniform particle. It comes in a range of sizes, broadly grouped into larger, more buoyant particles (HDL2) and smaller, denser ones (HDL3). Early research in Finnish men suggested that HDL2 was the subfraction most strongly linked to lower heart attack risk, while HDL3’s role was unclear.14PubMed. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction But subsequent studies complicated this. A large Canadian study found that while HDL2 had a statistically significant protective association and HDL3 fell just short of significance, the actual size of the difference between the two was small, and neither subfraction predicted heart disease better than plain total HDL cholesterol.15PubMed. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men British data from the Caerphilly and Speedwell studies even found a stronger protective association for HDL3 than HDL2, but again, no combination of the subfractions predicted disease better than total HDL alone.16PubMed. Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men
The bottom line on subfractions is that measuring them has not proven clinically useful beyond what a standard HDL cholesterol test provides. Your total HDL level, ideally supplemented by information about particle function, gives a more meaningful picture than trying to parse HDL2 versus HDL3.
Ethnic Differences in HDL and Heart Disease Risk
HDL levels vary across populations, and so does the relationship between those levels and actual heart disease outcomes. In a large multi-ethnic study in Amsterdam, mean HDL cholesterol ranged from about 50 mg/dL in participants of Turkish descent to about 63 mg/dL in participants of Ghanaian descent, and these differences persisted after adjusting for age and sex.17PubMed. Ethnic differences in plasma lipid levels in a large multiethnic cohort
More important than the level differences is the fact that the same HDL number does not predict risk equally across groups. In one study from Northern Manhattan, a drop in HDL of 10 mg/dL was associated with roughly a 50% higher risk of heart attack in non-Hispanic white participants, but showed no significant risk increase among Hispanic participants.18PubMed Central. Race-ethnic differences in the relationship between lipid profile components and risk of myocardial infarction A UK-based analysis found that while HDL was inversely associated with coronary heart disease across all ethnic groups studied, the strength of that association differed: it was substantially stronger in South Asian participants than in white participants, with certain HDL subfractions like large HDL particles showing particularly strong protective associations in South Asian individuals.19Atherosclerosis. Ethnic differences in HDL quantity, quality, and potential associations with coronary heart disease risk
These findings suggest that applying a single universal HDL threshold to everyone oversimplifies things. If you belong to a population where HDL’s relationship to heart disease differs from the average, a conversation with your doctor about context is more useful than fixating on whether you hit the 60 mg/dL mark.
How to Raise Your HDL
If your HDL is low, several lifestyle changes can push it upward and, just as importantly, improve how well your HDL particles function.
Exercise
Regular aerobic exercise is the most reliably studied way to raise HDL. Multiple studies and meta-analyses confirm that physical activity raises HDL cholesterol and also appears to improve HDL particle maturation and function.20PubMed Central. The Impact of Aerobic Exercise on HDL Quantity and Quality Both aerobic exercise and resistance training have favorable effects on lipid profiles, though the evidence is strongest for aerobic activity.21PubMed Central. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile There is some indication that a minimum exercise dose needs to be reached before HDL function (as measured by efflux capacity) improves, so occasional light walks may not be enough.22PubMed Central. Effects of exercise on HDL functionality Brisk walking, cycling, swimming, or jogging at a moderate to vigorous pace several times a week is a reasonable target.
Quitting Smoking
Smoking lowers HDL and damages its function. The good news is that quitting raises HDL cholesterol rapidly, often within three weeks.23PubMed Central. The effect of quitting smoking on HDL-cholesterol – a review based on within-subject changes Beyond just the number, smoking cessation has been shown to improve HDL’s cholesterol efflux capacity and reduce its inflammatory index, even when the total HDL cholesterol level and its protein components do not change much.24Circulation Journal. Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality HDL’s antioxidant ability also improves after quitting.25PubMed. The effects of cigarette smoking and smoking cessation on high-density lipoprotein functions This means quitting smoking is one of the few interventions that clearly improves both HDL quantity and quality.
Diet
Dietary fat composition influences HDL. A meta-analysis of 27 feeding trials found that replacing carbohydrates with any type of fat raised HDL, with saturated fat having the strongest effect and polyunsaturated fat having the smallest.26PubMed. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials That does not mean you should load up on saturated fat, because saturated fat also raises LDL cholesterol, which works against you. The practical advice is to favor unsaturated fats from sources like olive oil, nuts, avocados, and fatty fish, and to avoid replacing fat with refined carbohydrates, which tends to lower HDL.
Alcohol
Moderate alcohol consumption does raise HDL. One controlled study found that alcohol increased HDL cholesterol by about 18%, and the increase was dose-dependent, meaning more alcohol raised HDL more.27PubMed. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II The mechanism involves increased production of the main HDL proteins. However, no medical organization recommends starting to drink for the sake of your HDL. The cardiovascular risks of alcohol, including higher blood pressure, liver disease, and cancer risk, outweigh the modest HDL benefit for most people. If you already drink moderately, the HDL effect is a real physiological phenomenon, but it is not a reason to drink more.
Weight Loss
Losing excess weight generally improves lipid profiles, but the relationship between weight loss and HDL is surprisingly complex. Research has shown a paradoxical pattern: active weight loss can temporarily reduce HDL cholesterol, even as it improves other metabolic markers. Over time, maintaining a lower weight tends to raise HDL, but the trajectory is not always a smooth upward line.28PubMed. Weight loss and its influence on high-density lipoprotein cholesterol (HDL-C) concentrations If you see a temporary dip in HDL while actively losing weight, that is not necessarily a sign that something is going wrong.
Why Drugs That Raise HDL Have Mostly Failed
If higher HDL is protective, it seems logical that a drug that raises HDL should reduce heart attacks and strokes. That logical-sounding idea has been one of cardiology’s biggest disappointments. Three major classes of HDL-raising drugs, niacin, fibrates, and CETP inhibitors, have been tested in large trials, and none reduced deaths, heart attacks, or strokes when added to statin therapy.29BMJ. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors
The niacin story is particularly telling. In the AIM-HIGH trial, niacin added to statin therapy raised HDL from 35 to 42 mg/dL and lowered triglycerides and LDL. By every lipid-panel measure, the numbers looked better. But the trial was stopped early after about three years because niacin was not reducing cardiovascular events at all; the event rate was virtually identical in the niacin and placebo groups.30PubMed. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy A second large niacin trial confirmed the lack of benefit and flagged significant side effects.31PubMed Central. Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease
CETP inhibitors, which block a protein that transfers cholesterol from HDL to LDL and can dramatically boost HDL levels, also disappointed. Early programs ran into toxicity, futility, or at best marginal cardiovascular benefit.32PubMed. CETP Inhibitors: Back With a New Target
The failure of these drugs is actually consistent with the efflux-capacity research discussed earlier. Simply inflating the number of HDL particles or the cholesterol they carry does not necessarily produce particles that function better. It is like adding more trucks to a delivery fleet without hiring drivers. The quantity goes up, but the actual work being done may not change.
Experimental Approaches That Target HDL Function
Rather than raising HDL levels, some researchers are trying to directly boost HDL’s ability to do its job. The most advanced approach involves infusing patients with reconstituted HDL particles made from apolipoprotein A-I, the main structural protein of HDL. The idea is to flood the bloodstream with functional particles that can immediately start pulling cholesterol out of artery walls.
An early proof-of-concept trial using a synthetic version of a naturally occurring variant called apoA-I Milano showed a measurable reduction in artery plaque volume after just five weekly infusions.33PubMed Central. Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis However, subsequent programs using different formulations have had mixed results. Two of the three major apoA-I-based therapies tested so far (MDCO-216 and CER-001) failed to significantly reduce coronary plaque volume in phase II trials. A third agent, CSL112, which uses native human apoA-I rather than a synthetic variant, has shown stronger cholesterol-efflux boosting effects and is being tested in a large phase III trial for preventing recurrent events after heart attacks.34PubMed Central. ApoA-I Infusion Therapies Following Acute Coronary Syndrome, Past, Present, and Future Testing of the HDL mimetic CER-001 in patients with genetically very low HDL also showed no benefit on artery wall thickness or inflammation.35PubMed. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels
These therapies are still experimental, and none are available as standard treatments. But the research direction itself is significant: it reflects the broader recognition that the future of HDL-related therapy lies in improving what HDL does, not just how much of it shows up on a blood test.
Genetic Extremes and What They Teach Us
A small number of people have genetically determined very low or very high HDL. The most dramatic example is Tangier disease, a rare inherited condition in which HDL cholesterol, apoA-I, and apoA-II levels are a fraction of normal. Homozygous individuals (those with two copies of the mutation) have been found to have HDL cholesterol at about 4% of normal levels and apoA-I at only about 2% of normal. Heterozygous carriers have levels roughly half of normal.36PubMed Central. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier) People with Tangier disease develop cholesterol deposits in tissues like the tonsils and spleen, but their cardiovascular risk, while elevated, is not as extreme as you might expect from having almost no HDL. This has fueled the argument that HDL’s relationship with heart disease is not as simple as “more is always better.”
On the other end, people with genetically very high HDL do not always have the cardiovascular protection those levels would predict. Some genetic variants that raise HDL cholesterol do not improve HDL function or lower heart disease risk, which further supports the idea that the number itself is only a partial measure of what HDL is doing for you. These genetic edge cases have been some of the strongest evidence pushing researchers away from the simple “raise the number” approach and toward function-based thinking about HDL.